secwatch.observer — SEC 8-K summary
======================================

Issuer:     Outset Medical, Inc. (OM)
CIK:        0001484612
Form:       8-K
Filed at:   2026-06-17T20:05:17+00:00
Accession:  0001193125-26-274135
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 1.01, 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Outset Medical secures ~$40M HCA commitment for Tablo hemodialysis system refresh through 2028
--------------------------------------------------------------------------------

- HCA commits to purchase new Tablo hemodialysis consoles from 2026 through 2028 under Refresh Amendment; aggregate contract value ~$40M net of rebates.
- Term extended to Dec 31, 2028; existing consoles traded in for credit; HCA cannot terminate for convenience during refresh.
- Outset reiterates 2026 financial guidance; expects to provide more detail on deal's 2026 impact later this year.
- Amendment includes rebates, uptime guarantees, and support service fee terms; certain pricing details redacted as confidential.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/0001193125-26-274135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484612/000119312526274135/om-20260614.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-274135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer